The ASX wobbled as the Fed held its ground, ANZ slipped, Neuren raked in royalty cash, Orica shot up, and Pro Medicus locked in a US deal.
Neuren Pharmaceuticals says fewer US Rett syndrome patients are discontinuing its breakthrough drug Daybue.
Home loans with longer interest-only periods, offering lower initial repayments, are appearing in Australia as housing costs climb.
Hillgrove Resources is on track to hit its 14,000t production guidance, positioning it to reap the rewards of high copper prices.
Errawarra is gearing up for diamond drilling at its Elizabeth Hill silver project after locking in drilling contractor West Core Drilling.
